Research progress on immune mechanism of gastroesophageal reflux disease: immune inflammatory cascade acting as a novel therapeutic target

doi:10.3877/cma.j.issn.2095-7157.2022.03.006

Abstract

Abstract:

Gastroesophageal reflux disease (GERD) is a group of diseases with clinical manifestations and pathological changes caused by gastroduodenal content reflux into esophagus. Recently, some researchers have found that before the mucosal injury, the immune response occurred and caused the epithelial cells to vary in the pathogenesis of GERD. Meantime, the repair mechanism was activated, and acid / non acid reflux was the factor inducing immune and inflammatory response. So, to develop a novel treatment target, which can effectively block the occurrence of inflammatory cascade reaction attributed to reflux, would be a promising treatment of GERD.

Key words: Gastroesophageal reflux disease, Immune, Inflammatory, Pathogenesis, Treatment

Qianqian Chen, Yi Li, Enqiang Linghu. Research progress on immune mechanism of gastroesophageal reflux disease: immune inflammatory cascade acting as a novel therapeutic target[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2022, 09(03): 145-147.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhwcnjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-7157.2022.03.006

https://zhwcnjdzzz.cma-cmc.com.cn/EN/Y2022/V09/I03/145

Figures/Tables 1

References 14

[1]	Gyawali C, Prakash, Kahrilas Peter J，et al. Modern diagnosis of GERD: the Lyon Consensus[J]．Gut，2018，67(7): 1351-1362.
[2]	Katz Philip O, Dunbar Kerry B, Schnoll-Sussman Felice H, et al. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease[J]．Am J Gastroenterol，2022，117(1): 27-56.
[3]	Richter JE, Rubenstein JH. Presentation and Epidemiology of Gastroesophageal Reflux Disease[J]. Gastroenterology，2018，154(2):267-276.
[4]	Fock KM, Talley N, Goh KL, et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett′s oesophagus[J]．Gut，2016，65(9):1402-15.
[5]	Tariq Muhammad Ali, Ahmed Bilal. Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease[J]．J Neurogastroenterol Motil，2022，28(1): 164.
[6]	Nikolic M, Schwameis K, Paireder M，et al. Tailored modern GERD therapy-steps towards the development of an aid to guide personalized anti-reflux surgery[J]. Sci Rep，2019，9(1): 19174.
[7]	Iwakiri Katsuhiko, Fujiwara Yasuhiro, Manabe Noriaki, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021[J]．J Gastroenterol, 2022, 57(4): 267-285.
[8]	Dunbar KB, Agoston AT, Odze RD, et al. Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes[J]．JAMA，2016, 315(19):2104-1012.
[9]	Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury [J]．Gastroenterology，2009，137(5): 1776-1784.
[10]	Nan Li, Nam Hyeon Hwa, Choo Byung Kil，et al. Allium hookeriAn Ethanolic Extract of Root Alleviates Reflux Esophagitis and Modulates NF-B Signaling[J]．Evid Based Complement Alternat Med，2018，2018: 1834681.
[11]	Nejat Pish-Kenari F, Qujeq D, Maghsoudi H. Some of the effective factors in the pathogenesis of gastro-oesophageal reflux disease[J]. J Cell Mol Med，2018，22(12):6401-6404.
[12]	Huo X, Zhang X, Yu C，et al. In oesophageal squamous cells exposed to acidic bile salt medium omeprazole inhibits IL-8 expression through effects on nuclear factor-κB and activator protein-1[J]. Gut，2014，63(7):1042-1052.
[13]	Yu Hai-Xiang, Wang Xiao-Long, Zhang Le-Ning, et al. Involvement of the TLR4/NF-κB Signaling Pathway in the Repair of Esophageal Mucosa Injury in Rats with Gastroesophageal Reflux Disease[J]．Cell Physiol Biochem, 2018, 51(4): 1645-1657.
[14]	Hait Elizabeth J, McDonald Douglas R. Impact of Gastroesophageal Reflux Disease on Mucosal Immunity and Atopic Disorders[J]．Clin Rev Allergy Immunol, 2019，57(2):213-225.

[1]	Huazhi Li, Guang Cao, Diangang Liu, Yajing Zhang. Clinical comparison of descending hepatectomy with different approaches for primary hepatocellular carcinoma [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 52-55.
[2]	Jie Zhang, Xiaoxia Luo, Hong Yu. Predictive value of systemic immune inflammation index in patients with acute pancreatitis complicated with organ function impairment [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 68-71.
[3]	Hao Chen, Meng Wang. Advances in clinicopathological features and treatment options of sig-ring cell carcinoma of the stomach [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 108-111.
[4]	Zhizhao Zhang, Rui Wang, Pingping Gao, Chengfang Wang, Cheng Wang, Xiaowei Qi. Relationship between DNMT3B and prognosis of breast cancer and its biological mechanism [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 624-629.
[5]	Yuefang Xu, Wang Liu, Miaotian Zeng, Yushu Guo. Clinical efficacy of polymyxin B and polymyxin E in the treatment of surgical multi-drug resistant infections Security analysis [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 700-703.
[6]	Chengwang Fu, Dagang Yang, Rong Wang, Futang Li. Research progress of nutritional and inflammatory markers in resectable pancreatic cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 704-708.
[7]	Dawei Wang, Yafei Lu, Shaohua Huangfu, Yuting Chen, Ao Chen, Bin Jiang. Advances in immune modulating mechanisms of mesenchymal stem cells in promoting wound healing [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2024, 14(06): 361-366.
[8]	of Organ Transplantation of Chinese Medical Association Branch. Chinese practice guidelines for diagnosis and treatment of ischemic-type biliary lesion after liver transplantation [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 739-748.
[9]	Weijie Chen, Xiaodong He. Progress in immunotargeted therapy for gallbladder cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 763-768.
[10]	Anti-Cancer Association China, Committee of Colorectal Cancer CACA the. CACA guidelines for holistic integrative management of anal cancer （2024 Edition） [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 441-449.
[11]	Xuefeng Zhou, Zheyi Dong, Zhe Feng, Guangyan Cai, Xiangmei Chen. Formulation protocol of guidelines for diagnosis and treatment of diabetic kidney disease with integrated traditional Chinese and Western medicine [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 301-305.
[12]	Bin Shi, Yuan Si. Effect of Yiqiheluo formula combined with valsartan in the treatment of IgA nephropathy with deficiency of both qi and yin plus blood stasis syndrome [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 306-312.
[13]	Tianyu Wu, Zixuan Liu, Puxin Yang, Siming Jia, Kai Ding, Xiaodong Cheng, Yonglong Li, Wei Chen, Hongzhi Lyu, Qi Zhang. Progress in Conservative Treatment of Lumbar Disc Herniation [J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2024, 10(06): 379-384.
[14]	Zhan Wang, Wenkun Li, Yi Yang, Fang Xu, Minsi Zhou, Jiayi Su, Yadan Wang, Jing Wu. Application of inflammatory markers in early-onset colorectal tumors [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(09): 802-810.
[15]	Qi Liu, Shoukai Wang, Shuai Wang, Yuqing Su, Zhuang Ma, Haijun Chen, Pilei Si. Advances in research of intratumoral microbiome in breast cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(09): 841-845.

Please choose a citation manager

Content to export